FDA Warns Public Not to Get Too Excited About CBD
Just a few short years ago, CBD – the non-intoxicating cannabinoid found in hemp and marijuana to different degrees – was rather obscure. But as time wore on, word quickly spread about this allegedly miraculous health product.
In some ways, the public was not entirely wrong. CBD proved to be life-changing for epilepsy patients, with some preliminary studies indicating that it could help with several other issues, like inflammation.
However, the public turned a potential alternative health product into a fad, putting their faith into it with little else but anecdotal evidence to support it. It was not long before the public treated CBD like a cure-all.
Of course, the popularity led many aspiring businesspeople to enter the industry, flooding a once obscure market with substandard products.
But the FDA’s biggest concern is that individuals now believe CBD is completely safe to use. However, Forbes reports that the FDA is issuing warnings that cannabidiol is not the cure-all we hoped for.
Many people like to dismiss the warnings of the FDA, claiming the organization to be an advocate for “Big Pharma.” But a look at their CBD consumer report establishes legitimate concerns that cannot be ignored with conspiratorial thinking:
“The U.S. Food and Drug Administration (FDA) recognizes the significant public interest in cannabis and cannabis-derived compounds, particularly CBD. However, there are many unanswered questions about the science, safety, and quality of products containing CBD.”
An industry that grew unregulated for so long means that the FDA has their work cut out for them. But one particular area of concern is an observation during a landmark study in children with severe epilepsy.
Although the study showed notable improvements in the subjects’ quality of life, researchers also noticed reactions when CBD was combined with certain epilepsy medications. Specifically, increased liver function led to some patients reducing their dose of conventional medication, while a minority had to drop out entirely.
This begs the question as to whether other medications can result in the same problems. Taking prescription CBD under the care of a doctor is safer than simply buying it from a health supplement provider or dispensary, says the FDA.
The report also addresses unsubstantiated medical claims about CBD:
“Misleading and false claims associated with CBD products may lead consumers to put off getting important medical care, such as proper diagnosis, treatment, and supportive care… For example, the agency has warned companies selling CBD products they claim are intended to prevent, diagnose, treat, or cure serious diseases such as cancer, Alzheimer’s disease, psychiatric disorders and diabetes.”
It is not uncommon for many people to forego established medical treatment in favour of “natural” medicine (or none at all). CBD’s sudden rise in popularity only fuels the fire and increases the chances of people turning to it as a cure-all.
There are many websites and companies who, on the surface, sell high-quality CBD. But as the FDA points out in its consumer report, appearances are often deceiving:
“The FDA has also tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. We have also heard reports of CBD potentially containing contaminants (e.g., pesticides, heavy metals); we are looking into this.”
CBD supplements are not cheap. It is perfectly fair for consumers to get what they pay for.
WeedAdvisor’s Commitment to Consumer Safety
Overall, we do believe that CBD is safe when things like medications or other pre-existing conditions – especially those affecting the liver – are not present.
Still, there is a lot left to investigate, making it critical that we look at CBD through the lens of a regulating body, rather than the claims made exclusively by retailers or consumers.
With this in mind, WeedAdvisor urges everyone to proceed with caution and consult a medical provider when considering CBD. Meanwhile, we will continue our mission to educate the public as new information on CBD safety comes to light.